Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Tetrahydrocannabinol
Therapeutic Area : Psychiatry/Psychology
Study Phase : Undisclosed
Sponsor : Biopharmaceutical Research Company
Deal Size : Undisclosed
Deal Type : Collaboration
Details : The partnership with BRC, supports the study of Delta-9 THC products and formulations, allowing OBX to identify the phase appropriate, optimal products for formulations including Delta-9-tetrahydrocannabinol.
Brand Name : Delta-9 THC
Molecule Type : Small molecule
Upfront Cash : Undisclosed
June 14, 2022
Lead Product(s) : Tetrahydrocannabinol
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Undisclosed
Sponsor : Biopharmaceutical Research Company
Deal Size : Undisclosed
Deal Type : Collaboration
LOOKING FOR A SUPPLIER?